Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06004882 · ClinicalTrials.gov registry record · NA
Peripheral Nerve Stimulation of Genicular Nerves Versus Conventional Therapy With Intra-articular Steroid Injection for Chronic Knee Pain: A Prospective, Randomized Pilot Study
A NA study of Chronic Knee Pain and Peripheral Nerve Stimulation, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 45
- Enrollment target
- 1
- Study location
NCT06004882: Recruiting NA study of Chronic Knee Pain and Peripheral Nerve Stimulation, sponsored by M.D. Anderson Cancer Center.
NCT06004882 is a NA study of Chronic Knee Pain and Peripheral Nerve Stimulation that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 45 participants, below the 225-participant average among 5 other Chronic Knee Pain trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06004882, a NA study of Chronic Knee Pain and Peripheral Nerve Stimulation, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
To compare the effects of the following types of therapy on knee range of motion when given to patients with chronic knee pain: * A standard steroid injection * Peripheral nerve stimulation (PNS) therapy in combination with a standard steroid injection * PNS therapy in combination with a placebo injection Steroid injections are given directly into the knee joints and are considered to be the standard therapy for chronic knee pain. In this study, the injection will be made of the steroid drugs triamcinolone and bupivacaine.
Conditions Studied
Interventions
- DRUG Bupivacaine
- OTHER Placebo
- OTHER PNS therapy
- DRUG Triamcinolone
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2023-08-10 |
| Est. Completion | 2027-01-31 |
| Phase | NA |
What NCT06004882 shows while recruiting
NCT06004882 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 225-participant average among 5 other Chronic Knee Pain trials with a reported enrollment target (80% lower).
The record links to 3 conditions, with Chronic Knee Pain appearing as the primary indexed condition, and to 4 interventions - of which Bupivacaine is the first listed.
NCT06004882 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06004882 about?
NCT06004882 is a clinical study titled "Peripheral Nerve Stimulation of Genicular Nerves Versus Conventional Therapy With Intra-articular Steroid Injection for Chronic Knee Pain: A Prospective, Randomized Pilot Study". To compare the effects of the following types of therapy on knee range of motion when given to patients with chronic knee pain: * A standard steroid injection * Peripheral nerve stimulation (PNS) therapy in combination with a standard steroid injection * PNS therapy in combination with a placebo in...
What is the current status of trial NCT06004882?
This trial is currently recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2023-08-10. Estimated completion is 2027-01-31.
What conditions does trial NCT06004882 study?
This clinical trial studies the following conditions: Chronic Knee Pain, Peripheral Nerve Stimulation, Genicular Nerves.
What interventions are being tested in trial NCT06004882?
The interventions under investigation include: Bupivacaine (DRUG), Placebo (OTHER), PNS therapy (OTHER), Triamcinolone (DRUG).
Who is sponsoring clinical trial NCT06004882?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06004882 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Knee Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluating the Auricular Point Acupressure-Self Management Program for Chronic Musculoskeletal Pain Among Rural Populations
RECRUITING · NA
-
Radiofrequency Ablation After Total Knee Arthroplasty
ACTIVE NOT RECRUITING · NA
-
Radiofrequency For Chronic Knee Pain Post-Arthroplasty
COMPLETED · NA
-
Individual Differences in Gait and Osteoarthritis Pain
RECRUITING
-
Brain Biomarker of Endogenous Analgesia in Patients With Chronic Knee Pain
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI